Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Allergan investors still too 'skeptical' about a Pfizer merger, analyst says
Allergan investors still too 'skeptical' about a Pfizer merger, analyst says
Allergan investors still too 'skeptical' about a Pfizer merger, analyst says
Submitted by
admin
on December 1, 2015 - 8:55pm
Source:
Fierce Pharma
News Tags:
Allergan
investors
Pfizer
M&A
Headline:
Allergan investors still too 'skeptical' about a Pfizer merger, analyst says
Do Not Allow Advertisers to Use My Personal information
